A Study to Assess the Safety, Tolerability, and Efficacy of IONIS-GHR-LRx Administered in Patients With Acromegaly
Status:
Recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety, tolerability, and efficacy of
IONIS-GHR-LRx subcutaneous (SC) injection as monotherapy in patients with acromegaly.